It reflects fundamentally different service models, different levels of clinical oversight, and in many cases, different standards for what is actually included in the quoted price
Next-Gen Incretin-based Therapies Next-gen incretin-based therapies are one of the key focuses for obesity biotech, with companies racing to develop improved versions of GLP-1 and targeting different targets that has an effect on satiety to offer better efficacy and tolerability
Drugs (e.g., calcium channel blockers, opiates, antispasmodics, antidepressants) [9] altered autonomic outflow and bowel muscle contraction [10] Endocrine pathology (e.g., hypothyroidism) downregulated bowel motility Neurological pathology (e.g., spinal injury, enteric neuropathy) disease or trauma of bowel innervation Ineffective peristalsis difficult passage of stool regardless of stool consistency sensation of incomplete and irregular bowel emptying References: [10] [11] Approach to management Manage complications Identify and treat fecal impaction
Front Endocrinol 13:1046130 Inia JA, Stokman G, Morrison MC, Worms N, Verschuren L, Caspers MPM, Menke AL, Petitjean L, Chen L, Petitjean M, Jukema JW, Princen HMG, van den Hoek AM (2023) Semaglutide Has Beneficial Effects on Non-Alcoholic Steatohepatitis in Ldlr-/-.Leiden Mice
LncRNA GAS6-AS1 contributes to 5-fluorouracil resistance in colorectal cancer by facilitating the binding of PCBP1 with MCM3
